General MedicationsORALStandard
CEFACLOR
CEFACLOR
Standard Dose
EQ 375MG BASE/5ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: UNKNOWN Marketing status: Prescription
Summary
Approval overview CEFACLOR is listed in Drugs@FDA under application 065412 (ANDA).
Review priority: UNKNOWN Marketing status: Prescription Active ingredient CEFACLOR Form and strength FOR SUSPENSION;ORAL - EQ 375MG BASE/5ML Sponsor YUNG SHIN PHARM Submission history Latest submission status date: 2024-12-23 00:00:00.
Structured Monograph
Clinical summary
Approval overview CEFACLOR is listed in Drugs@FDA under application 065412 (ANDA). Review priority: UNKNOWN Marketing status: Prescription Active ingredient CEFACLOR Form and strength FOR SUSPENSION;ORAL - EQ 375MG BASE/5ML Sponsor YUNG SHIN PHARM Submission history Latest submission status date: 2024-12-23 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: UNKNOWN
Interaction Notes
- No interaction notes stored yet.